Search

Your search keyword '"Nchinda, Aloysius T."' showing total 47 results

Search Constraints

Start Over You searched for: Author "Nchinda, Aloysius T." Remove constraint Author: "Nchinda, Aloysius T."
47 results on '"Nchinda, Aloysius T."'

Search Results

1. 1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis

2. 1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis

3. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates

5. Correction to “Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium falciparum NSG Mouse Model”

6. Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium falciparum NSG Mouse Model

7. Lerisetron Analogues with Antimalarial Properties: Synthesis, Structure–Activity Relationship Studies, and Biological Assessment

11. Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”

12. Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose–Response Curves against Multidrug Resistant Parasite Strains

13. UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

14. Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγnull Mouse Model of Malaria

15. Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In VivoEfficacy in the Plasmodium falciparumNSG Mouse Model

16. Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle

17. Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγnull Mouse Model of Malaria.

18. Medicinal Chemistry Optimization of Antiplasmodial Imidazopyridazine Hits from High Throughput Screening of a SoftFocus Kinase Library: Part 1

19. 2,4-Diaminothienopyrimidines as Orally Active Antimalarial Agents

20. Structure–Activity-Relationship Studies around the 2-Amino Group and Pyridine Core of Antimalarial 3,5-Diarylaminopyridines Lead to a Novel Series of Pyrazine Analogues with Oral in Vivo Activity

21. Structure–Activity Relationship Studies of Orally Active Antimalarial 3,5-Substituted 2-Aminopyridines

22. 3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential

23. Novel Orally Active Antimalarial Thiazoles

36. Medicinal Chemistry Optimizationof AntiplasmodialImidazopyridazine Hits from High Throughput Screening of a SoftFocusKinase Library: Part 1.

37. 2,4-Diaminothienopyrimidinesas Orally Active AntimalarialAgents.

38. Structure–Activity-RelationshipStudies aroundthe 2-Amino Group and Pyridine Core of Antimalarial 3,5-DiarylaminopyridinesLead to a Novel Series of Pyrazine Analogues with Oral in Vivo Activity.

39. Structure–ActivityRelationship Studies ofOrally Active Antimalarial 3,5-Substituted 2-Aminopyridines.

41. Chromone Studies. Part 11.1Synthesis and Electron-Impact Mass Spectrometric Study of Granulosin and Side-Chain Analogues†

43. Correction to “Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In VivoEfficacy in the Plasmodium falciparumNSG Mouse Model”

44. Chromone Studies. Part 14.1Unprecedented Dimerisation of Chromone-3-Carbaldehyde-Derived Baylis–Hillman Adducts

45. Chromone studies. Part 10.1Substituent effects on the basicity of 2-(N,N-dimethylamino)chromones†

46. Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparumPI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”

47. UCT943, a Next-Generation Plasmodium falciparumPI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

Catalog

Books, media, physical & digital resources